Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non–Small Cell Lung Cancer in the United States.
- Resource Type
- Article
- Source
- JAMA Network Open; 9/25/2019, Vol. 2 Issue 9, pe1911952-e1911952, 1p
- Subject
- Language
- ISSN
- 25743805